$4550
$3640
The Pacemakers market was valued at US$ 5,485.4 million in 2018 and it is projected to reach US$ 10,908.0 million by 2027; it is expected to grow at a CAGR of 8.1% from 2019 to 2027.
Pacemakers are battery operated medical devices that are placed in the chest or abdomen and help in regularizing the heart beats. Pacemakers are advised for medical conditions such as, bradycardia and heart block. A pacemaker is also suggested for the geriatric population, as normal aging of the heart may disrupt the normal heart rate, making it beat too slowly. Certain pacemakers also come along with sensors that detect body motion or breathing rate, and signals the pacemaker to increase heart rate during exercise to meet the body's increased need for blood and oxygen. The growth of the Pacemakers market is attributed to the increasing burden of cardiovascular diseases, neurological disorders & hearing disorders, increasing technological advancements, and large pool of geriatric population. Additionally, the future trends such as product innovations is likely to increase the growth of the pacemakers market in the forecasted period.
The Pacemakers market is expected to witness substantial growth post-pandemic. The Pacemakers market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Pacemakers market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Applications of Pacemakers in Healthcare to Drive Pacemakers market Growth
The increasing technological advancements have opened more opportunities of developing new and innovative medical implantable pacemakers with advanced electrical properties that can improve diagnosis and treatment of previously intractable conditions such as, cardiovascular diseases that includes cardiac arrhythmia, atrial fibrillation and others. A pacemaker is an electronic device designed to produce electrical impulses to stimulate the heart when normal physiological stimulation fails.
In 2017, according to the World health organization, the increasing prevalence of cardiovascular diseases is the major cause of death all over the world. Moreover, it was mentioned that 17.9 million people across the globe died due to cardiovascular diseases in 2016. Cardiovascular disease is one of the leading causes of morbidity and mortality and is responsible for 30% of worldwide mortality, according to the World Health Organization. Moreover, according to the Centers of Disease Control and Prevention, Coronary heart disease (CHD) is the most common type of heart disease, killing over 370,000 people annually.
Furthermore, according to the American Heart Association, in 2016, Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease in the US, followed by stroke (16.9%), High Blood Pressure (9.8%), Heart Failure (9.3%), diseases of the arteries (3.0%), and other cardiovascular diseases (17.7%). Moreover, the Global Burden of Disease study in 2016 estimates that age-standardized CVD death rate due to cardiovascular diseases is 272 per 100 000 population in India is higher than the global average of 235 per 100 000 population.
Thus, such high prevalence of cardiovascular diseases globally is anticipated to lead the market growth in the coming years.
In an aging society where chronic conditions such as cardiovascular diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Electronic implants are playing a pioneering role that help to detect specific medical parameters. Additionally, these implants are able to take immediately autonomous therapeutic measures, combining diagnosis and treatment in a single system.
Electronic medical implant is an emerging field in the medical industry and has led to various developments of the products, in the field of cardiology, neurology and otology. Many of the market players are developing novel products in order to minimize the burden of cardiovascular diseases, neurological disorders and hearing disorders. For instance, Boston Scientific Corporation in September 2017, launched the Resonate family of Implantable Cardioverter Defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. This product is powered by EnduraLife battery technology, which has double battery capacity as compared to other devices.
Thus increasing the longevity of devices and managing heart failure more efficiently. Similarly, in November 2017, Medtronic launched Azure pacemakers with BlueSync technology that increases the life of the pacemakers, thus reducing the number of device replacements.
It also enables to secure and automatic wireless data transmission to physicians. Therefore, the pacemakers market is anticipated to grow due to technological advancements and rapid product launches.
The high growth of the market is anticipated on account of the rising global geriatric population. In both males as well as females, the risk of cardiovascular diseases increases with increase in age. Increasing age makes the blood vessels less flexible and reduction in blood flow. Thus, the risk of heart disease is high in elder population. Also, according to the Heart Disease and Stroke Statistics 2018, average age at the first heart attack is 65.6 years for males and 72.0 years for females. It also mentioned that annual incidence of heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks.
According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050. The number of geriatric population is expected to grow significantly in Africa followed by North America, Latin America & the Caribbean, and Asia Pacific region.
The elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the cardiovascular diseases has increased. Therefore, the demand of pacemakers market are expected to increase in the forecast period. Hence, the increasing global geriatric population is likely to boost the market growth during the forecast period.
Product Type-Based Insights
In terms of product type, the Pacemakers market is segmented into implantable pacemakers, external pacemakers. In 2018, the implantable pacemakers segment held the largest share of the market, by product type. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at a fastest CAGR of 8.4% during 2019 to 2027.
Pacemakers market, by Product Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-Based Insights
Based on application, the Pacemakers market is segmented into single, chambered, dual chambered, and bi-ventricular. In 2018, the single chambered segment held the largest share of the market, by technology. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at a fastest CAGR of 8.2% during 2019 to 2027.
End User-Based Insights
In terms of end user, the Pacemakers market is segmented into hospitals, ambulatory surgical centers, and others. In 2018, the hospitals segment held the largest share of the market, by end user. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to the advantages of the hospitals segments.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pacemakers Market: Strategic Insights
Market Size Value in US$ 5,485.4 Million in 2018 Market Size Value by US$ 10,908.0 Million by 2027 Growth rate CAGR of 8.1% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pacemakers Market: Strategic Insights
| Market Size Value in | US$ 5,485.4 Million in 2018 |
| Market Size Value by | US$ 10,908.0 Million by 2027 |
| Growth rate | CAGR of 8.1% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The Pacemakers market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Pacemakers market – by Product Type
- Implantable Pacemakers
- External Pacemaker
Pacemakers market – by Technology
- Single Chambered
- Dual Chambered
- Bi-Ventricular
Pacemakers market – by End User
- Hospitals
- Ambulatory Surgical Centres
- Others
Pacemakers market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Medico S.p.A.
- Vitatron
- Abbott
- Medtronic
- OSCOR
- LivaNova Plc
- Abiomed
- Boston Scientific Corporation
- Biotronik
- Zimmer Biomet
- Lepu Medical
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type By Technology , By End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
The List of Companies - Pacemakers Market
- Medico S.p.A.
- Vitatron
- Abbott
- Medtronic
- OSCOR
- LivaNova Plc
- Boston Scientific Corporation
- Biotronik
- Pacetronix
- Lepu Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2019
Pharmacy Automation Systems Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Automation Medication Dispensing Systems (Product Type and Operation), Automated Packaging and Labelling Systems, Automated Table-Top Counters, Automated Storage and Retrieval Systems, and Other Types], End User (Hospital Pharmacy, Retail Pharmacy, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
DNA Extraction, Isolation, and Purification Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa and South and Central America)
Jun 2019
Molecular Diagnostic for Infectious Diseases Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Point-of-Care Testing and Laboratory Testing), End User [Point-of-Care Testing (Human Testing and Vet Testing) and Laboratory Testing (Human Testing and Vet Testing)], Application [Point-of-Care Testing (Detection of Single Pathogen, Detection of Two or More Pathogens, Evaluation of Emerging Novel Infections, Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker, and Antimicrobial Resistance Profiling) and Laboratory Testing (Patient stratification, Drug Regimen Selection, Toxicity Avoidance, Therapeutic Monitoring, and Detection of Predisposition to Disease)], Disease Type [Point-of-Care Testing (Sepsis, Prosthetic Joint Infection, Endocarditis, STDs, Mononucleosis, Group A Streptococcus, and Others) and Laboratory Testing (Sepsis, Prosthetic Joint infection, Endocarditis, STDs, Chlamydia, Gastrointestinal Infection, Tuberculosis, H1N1 Virus, and Others)], Infection Type [Point-of-Care Testing (Bacteria, Viral, Fungi, and Others) and Laboratory Testing (Bacteria, Viral, Fungi, and Others)], and Geography (North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa)
Jun 2019
Bovine Diagnostics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2019
Endoscopy Procedures Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc.)], Product Type (Disposable and Reusable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Dental Bone Graft Substitutes and Barrier Membrane Market
Forecast to 2030 - Global Analysis by Product [Dental Bone Graft Substitutes (Allograft, Xenograft, Synthetic Bone Graft, Autografts, Alloplasts, Demineralized Bone Matrix (DBM-Allograft, and Others) and Dental Barrier Membrane (Resorbable Membrane and Non-Resorbable Membrane)], Procedure [Guided Bone Regeneration Procedures (GBR), Guided Tissue Regeneration Procedures (GTR), Sinus-Lift Procedures and Ridge-Split Procedures, Alveolar Ridge Preservation (ARP), Block-Graft Procedures, Periodontal Regeneration Procedures, Socket Preservation, and Others], End User (Hospitals, Dental Clinics, and Others), and Geography
Jun 2019
Lung Cancer Screening Market
Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
Jun 2019
Digital Thoracic Drainage Devices Market
Forecast to 2030 - Global Analysis by Product Type (Single Chamber and Multiple Chambers), Application (Cardiac Surgeries, Thoracic and Pulmonary Surgery, Oncology and Trauma, Infectious Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography